20 participants
Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-07-20
- Start Date:
- 2022-08-02
- Completion:
- 2024-08-02
Conditions
- AML
Interventions
- BIOLOGICAL
No Results Yet